
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+1
Candel ($CADL) is a clinical stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. Candel has established two clinical stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-3110 is the lead product candidate from the HSV platform and is currently in an ongoing investigator-sponsored phase 1 clinical trial in recurrent high-grade glioma (HGG). In addition, Candels enLIGHTENTM Discovery Platform is a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new...
Immuno-oncology,oncology,viral immunotherapy,prostate cancer,brain cancer,and biotechnology
Candel therapeutics operates in the Biotechnology research industry.
Candel therapeutics's revenue is 11m - 100m
Candel therapeutics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.